These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 29739804)
1. Etiology and treatment of adrenoleukodystrophy: new insights from Gordon HB; Valdez L; Letsou A Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29739804 [TBL] [Abstract][Full Text] [Related]
2. Neurodegeneration in a Drosophila model of adrenoleukodystrophy: the roles of the Bubblegum and Double bubble acyl-CoA synthetases. Sivachenko A; Gordon HB; Kimball SS; Gavin EJ; Bonkowsky JL; Letsou A Dis Model Mech; 2016 Apr; 9(4):377-87. PubMed ID: 26893370 [TBL] [Abstract][Full Text] [Related]
3. ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy. Morita M; Shimozawa N; Kashiwayama Y; Suzuki Y; Imanaka T Curr Drug Targets; 2011 May; 12(5):694-706. PubMed ID: 21039332 [TBL] [Abstract][Full Text] [Related]
4. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction. Wiesinger C; Kunze M; Regelsberger G; Forss-Petter S; Berger J J Biol Chem; 2013 Jun; 288(26):19269-79. PubMed ID: 23671276 [TBL] [Abstract][Full Text] [Related]
5. Preventing neurodegeneration in the Drosophila mutant bubblegum. Min KT; Benzer S Science; 1999 Jun; 284(5422):1985-8. PubMed ID: 10373116 [TBL] [Abstract][Full Text] [Related]
6. [X-linked adrenoleukodystrophy]. Aubourg P Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287 [TBL] [Abstract][Full Text] [Related]
14. X-linked adrenoleukodystrophy and primary adrenal insufficiency. Cappa M; Todisco T; Bizzarri C Front Endocrinol (Lausanne); 2023; 14():1309053. PubMed ID: 38034003 [TBL] [Abstract][Full Text] [Related]
15. Eight novel mutations in the ABCD1 gene and clinical characteristics of 25 Chinese patients with X-linked adrenoleukodystrophy. Chu SS; Ye J; Zhang HW; Han LS; Qiu WJ; Gao XL; Gu XF World J Pediatr; 2015 Nov; 11(4):366-73. PubMed ID: 26454440 [TBL] [Abstract][Full Text] [Related]
17. [Examination of very long chain fatty acids in diagnosis of x-linked adrenoleukodystrophy]. Stradomska TJ; Tylki-Szymańska A Pediatr Pol; 1996 Mar; 71(3):197-201. PubMed ID: 8966090 [TBL] [Abstract][Full Text] [Related]
18. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes. Singh J; Khan M; Singh I J Lipid Res; 2011 Nov; 52(11):2056-69. PubMed ID: 21891797 [TBL] [Abstract][Full Text] [Related]
19. A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy. Heinzer AK; Watkins PA; Lu JF; Kemp S; Moser AB; Li YY; Mihalik S; Powers JM; Smith KD Hum Mol Genet; 2003 May; 12(10):1145-54. PubMed ID: 12719378 [TBL] [Abstract][Full Text] [Related]
20. Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy. Raas Q; van de Beek MC; Forss-Petter S; Dijkstra IM; Deschiffart A; Freshner BC; Stevenson TJ; Jaspers YR; Nagtzaam L; Wanders RJ; van Weeghel M; Engelen-Lee JY; Engelen M; Eichler F; Berger J; Bonkowsky JL; Kemp S J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33690217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]